Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03951610 · ClinicalTrials.gov registry record · NA

A Dispensing Comparison of a Test Daily 1 Day Lens Against a Control 1 Day Lens.

A NA study of Myopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
52
Enrollment target
2
Study locations

NCT03951610 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 52 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03951610, a NA study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare the dispensing performance of somofilcon A test 1 day contact lens against somofilcon A control 1 day contact lens.

Conditions Studied

Myopia

Interventions

  • DEVICE Test lens
  • DEVICE Control lens

Study Locations (2)

California

  • University Eye Center at Ketchum Health - Anaheim

Indiana

  • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2019-02-21
Est. Completion 2019-06-04
Phase NA

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03951610

The ClinicalTrials.gov registry entry for NCT03951610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Test lens is the first listed.

NCT03951610 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Indiana.

Frequently Asked Questions

What is clinical trial NCT03951610 about?

NCT03951610 is a clinical study titled "A Dispensing Comparison of a Test Daily 1 Day Lens Against a Control 1 Day Lens.". The purpose of this study is to compare the dispensing performance of somofilcon A test 1 day contact lens against somofilcon A control 1 day contact lens.

What is the current status of trial NCT03951610?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2019-02-21. Estimated completion is 2019-06-04.

What conditions does trial NCT03951610 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT03951610?

The interventions under investigation include: Test lens (DEVICE), Control lens (DEVICE).

Who is sponsoring clinical trial NCT03951610?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03951610 being conducted?

This trial has 2 study locations across California, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.